Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
Two (2) dose levels of Proellex or placebo will be administered once-daily for up to 91 days.
Following screening and a pre-treatment endometrial biopsy, subjects will be followed monthly
for the three month treatment phase.